Bliss GVS Pharma informs about disclosure

03 May 2025 Evaluate

Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Bliss GVS Pharma has informed that the company had invoked arbitration proceedings against Pan Pharmaceuticals (Nairobi, Kenya) for recovery of its outstanding dues by way of filing a petition seeking appointment of an arbitrator before the Supreme Court of India. The details required to be disclosed under SEBI Circular SEBI/HO/CFD/CFD-PoD1/P/CIR/2023/123 dated July 13, 2023, is enclosed as Annexure-A.

The above information is a part of company’s filings submitted to BSE.

Bliss GVS Pharma Share Price

163.70 -8.45 (-4.91%)
19-Jan-2026 14:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1681.00
Dr. Reddys Lab 1171.15
Cipla 1397.25
Zydus Lifesciences 880.40
Lupin 2176.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×